Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1996
12/05/1996CA2220955A1 A novel human purinergic p2u receptor
12/05/1996CA2220648A1 Coanda effect gene delivery instrument and method of use
12/05/1996CA2220530A1 Improved method for obtaining full-length cdna sequences
12/05/1996CA2219861A1 .delta.p62, variants thereof, nucleic acid sequences and uses thereof
12/04/1996EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
12/04/1996EP0745849A2 Sample processing method for whole blood
12/04/1996EP0745690A2 Detectably labeled dual conformation oligonucleotide Probes, Assays and Kits
12/04/1996EP0745686A1 The use of DNA polymerase 3'-intrinsic editing activity
12/04/1996EP0745678A2 Novel microorganism, its use and process for the preparation of L-alpha-aminoacids
12/04/1996EP0745676A1 Thermostable DNA polymerases
12/04/1996EP0745675A2 A method of amplifying nucleic acid and a reagent therefor
12/04/1996EP0745674A2 Helicobacter polypeptides, their production and use
12/04/1996EP0745673A2 Catalytic antibody regulated prodrug therapy
12/04/1996EP0745672A2 Production of recombinant factor VIII in the presence of liposome-like substances of mixed composition
12/04/1996EP0745671A2 Recombinant DNA sequences encoding feedback inhibition released enzymes, plasmids comprising the recombinant DNA sequences, transformed microorganisms useful in the production of aromatic amino acids, and a process for preparing aromatic amino acids by fermentation
12/04/1996EP0745668A2 DNA coding for sulfotransferase
12/04/1996EP0745140A1 Circularizing nucleic acid probe able to interlock with a target sequence through catenation
12/04/1996EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy
12/04/1996EP0745135A1 Method for exponential amplification of nucleic acid by a single unpaired primer
12/04/1996EP0745134A1 Nucleic acid delivery system, method of synthesis and uses thereof
12/04/1996EP0745133A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
12/04/1996EP0745131A1 Targeting gene therapy
12/04/1996EP0745130A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay
12/04/1996EP0745129A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
12/04/1996EP0745128A1 Hepatitis b virus mutants, reagents and methods for detection
12/04/1996EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development
12/04/1996EP0745126A1 High lysine derivatives of alpha-hordothionin
12/04/1996EP0745125A1 Hematopoietic protein and materials and methods for making it
12/04/1996EP0745124A1 Mammalian cell cycle protein
12/04/1996EP0745123A1 pp32: A NEWLY IDENTIFIED CD45-ASSOCIATED PROTEIN
12/04/1996EP0745122A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
12/04/1996EP0745121A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0745092A1 Peptide inhibitors of urokinase receptor activity
12/04/1996EP0745091A1 Use of angiotensin ii analogs in tissue repair
12/04/1996EP0744958A1 Polyclonal antibody libraries
12/04/1996EP0744956A1 Peptides and methods against diabetes
12/04/1996EP0744953A1 Erythropoietin analog compositions and methods
12/04/1996EP0744901A1 Isolation of lactoferrin from milk
12/04/1996EP0744894A1 Self-assembling multimeric nucleic acid constructs
12/04/1996EP0744891A1 Transgenic fibrinogen
12/04/1996EP0744888A1 Corn plants and products with improved oil composition
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/04/1996CN1137294A Use of alpha-1,4-glucan lyase for preparation of 1,5-D-anhydrofructose
12/04/1996CN1137293A Gene encoding carboxypeptidase of aspergillus niger
12/04/1996CN1137289A Protease-containing cleaning compositions
12/04/1996CN1137288A Bleaching compositions comprising protease enzymes
12/03/1996US5581476 Computer-based methods and articles of manufacture for preparing G-CSF analogs
12/03/1996US5580990 Medical diagnosis
12/03/1996US5580969 Antisense oligonucleotides directed against human ICAM-I RNA
12/03/1996US5580968 Useful in diagnosing and following the course of rheumatoid arthitis
12/03/1996US5580967 Optimized catalytic DNA-cleaving ribozymes
12/03/1996US5580958 Dna binding protein
12/03/1996US5580859 Biological injections into mamalian muscle of dna to express a therapeutic protein, polypeptide or peptide; vaccines; administering a dystrophin gene correcting muscular dystrophy
12/03/1996US5580852 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
12/03/1996US5580788 Use of immunoglogulin-binding artificial proteins as molecular weight markers
12/03/1996US5580787 Nontoxic food starter culture
12/03/1996US5580782 Acetic acid bacterium, plasmid derived from said bacterium and shuttle vectors constructed with said plasmid
12/03/1996US5580777 Generation of neural precursor cell lines
12/03/1996US5580776 Having genetic material stably incorporated
12/03/1996US5580775 Excitatory amino acid neurotransmission in cns synapses
12/03/1996US5580774 Anticarcinogenic agents
12/03/1996US5580771 Phosphodiesterases catalyze hydrolysis of cyclic nucleotides, and control cellular concentration of cyclic nucleotides
12/03/1996US5580768 Method for the production of proteins in plant fluids
12/03/1996US5580767 Some of internucleotide linkages within oligonucleotide are phosphorothioate linkages
12/03/1996US5580766 A mutated oncoretroviral gag capsid protein containing a nuclear localization signal and an exogenous gene to allow the exogenous gene to enter in the nucleus of a target cell to allo integration into the genome
12/03/1996US5580761 Method of conferring resistance to immunodeficiency viral infection
12/03/1996US5580760 FUSE binding protein and cDNA therefor
12/03/1996US5580759 Polymerase chain reaction joining of dna molecules
12/03/1996US5580758 For insertion into gene which expresses protein secretion in bordetello
12/03/1996US5580757 Culturing mammalian cell transformed with recombinant vector including nucleotide sequence encoding cleavage site sandwiched between galactosidase and protein a coding sequences, recovering expressed fusion protein, cleaving
12/03/1996US5580756 Ligand which is reactive with the cd28 receptor on t cells
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
12/03/1996US5580754 Culturing; transformation; transfection; isolation
12/03/1996US5580753 DNA encoding the human cytokine, interleukin-9
12/03/1996US5580752 Genetic engineering
12/03/1996US5580739 Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
12/03/1996US5580738 Delta-like gene expressed in neuroendocrine tumors
12/03/1996US5580737 High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
12/03/1996US5580736 Having a cell with a reporter gene linked to a dna sequence comprising a protein binding site, a first and second fusiongene; interacting the binding proteins expressed; measuringthe expression of the reporter gene
12/03/1996US5580734 Method of producing a physical map contigous DNA sequences
12/03/1996US5580732 Method of DNA sequencing employing a mixed DNA-polymer chain probe
12/03/1996US5580729 Generalized method for cancer assessment
12/03/1996US5580727 Amli-MTg8 fusion protein resulting from T(8;21) translocation in acute myeloid leukemia
12/03/1996US5580725 Method of eliminating genetic routes for bacteriophage evolution and products produced thereby
12/03/1996US5580723 Comparing the activities of a segment-substituted polypeptide and the parent polypeptide; borrowing receptor binding properties from functionally divergent hormones
12/03/1996US5580722 Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
12/03/1996US5580721 Assays for inhibitors of myc oncoprotein
12/03/1996US5580719 Isolating genomic rna from poliovirus, employing rna sequencing to determine nucleotide at position 2493
12/03/1996US5580718 Oligonucleotides
12/03/1996US5580717 Recombinant library screening methods
12/03/1996US5580716 Parasite-derived resistance
12/03/1996US5580703 Human adeno-associated virus integration site DNA and uses thereof
12/03/1996US5580564 A pseudorabies virus having the replacement of the inducible promoter sequence of the immediate early gene to control tissue specificity; vaccines
12/03/1996US5580560 Modified factor VII/VIIa
12/03/1996US5580559 Hybrid plasminogen activator
12/03/1996US5580558 Delivery of gene products via mesangial cells
12/03/1996CA2177883A1 Polypeptides, their production and use
12/03/1996CA2028140C Novel bacteriocin compositions for use as enhanced broad range
12/03/1996CA1338771C Adhesion receptor for laminin and its use